STOCKHOLM, Sweden--(BUSINESS WIRE)--Vitrolife (STO:VITR) has received notice of allowance regarding patent in the USA for Steen Solution™, a solution for functional testing of lungs outside the body before transplantation. The patent contains both product and method claims, which means that both the composition of the solution and its use will be patent protected.
